Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

ClinicalTrials.gov ID: NCT03772587

Public ClinicalTrials.gov record NCT03772587. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety, tolerability, and efficacy of M281 administered to participants with generalized myasthenia gravis (gMG) who have an insufficient clinical response to ongoing standard of care therapy.

Study identification

NCT ID
NCT03772587
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Momenta Pharmaceuticals, Inc.
Industry
Enrollment
68 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 10, 2019 (Actual)
Primary completion
Jun 25, 2020 (Actual)
Completion
Jun 25, 2020 (Actual)
Last update posted
Jun 27, 2023

2019 – 2020

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
29
Facility City State ZIP Site status
Momenta Investigational Site Phoenix Arizona 85013 —
Momenta Investigational Site Tucson Arizona 85724 —
Momenta Investigational Site Los Angeles California 90048 —
Momenta Investigational Site Orange California 92868 —
Momenta Investigational Site Stanford California 94305 —
Momenta Investigational Site Aurora Colorado 80045 —
Momenta Investigational Site New Haven Connecticut 06511 —
Momenta Investigational Site Boca Raton Florida 33487 —
Momenta Investigational Site Maitland Florida 32751 —
Momenta Investigational Site Port Charlotte Florida 33952 —
Momenta Investigational Site St. Petersburg Florida 33713 —
Momenta Investigational Site Augusta Georgia 30912 —
Momenta Investigational Site Meridian Idaho 83642 —
Momenta Investigational Site Lake Barrington Illinois 60010 —
Momenta Investigational Site Fairway Kansas 66205 —
Momenta Investigational Site Boston Massachusetts 02114 —
Momenta Investigational Site Boston Massachusetts 02115 —
Momenta Investigational Site Boston Massachusetts 02215 —
Momenta Investigational Site Detroit Michigan 48202 —
Momenta Investigational Site East Lansing Michigan 48824 —
Momenta Investigational Site Columbia Missouri 65212 —
Momenta Investigational Site New Brunswick New Jersey 08550 —
Momenta Investigational Site New York New York 10021 —
Momenta Investigational Site Charlotte North Carolina 28207 —
Momenta Investigational Site Durham North Carolina 27710 —
Momenta Investigational Site Raleigh North Carolina 27607 —
Momenta Investigational Site Cincinnati Ohio 45267 —
Momenta Investigational Site Columbus Ohio 43210 —
Momenta Investigational Site Cordova Tennessee 38106 —
Momenta Investigational Site Austin Texas 78756 —
Momenta Investigational Site Round Rock Texas 78681 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03772587, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 27, 2023 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03772587 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →